Latest News

July 08, 2002
WHAT A celebration of the Avon Foundation’s gifts of $12.2 million (to-date) to the partnership between San Francisco General Hospital Medical Center (SFGHMC) and University of California, San Francisco (UCSF) The UCSF digital Mammovan, supported in part by Avon funds, will be available for tours at approximately 11:30 on the street at 401 Van Ness WHERE Veteran’s Building at 401 Van Ness Ave, San Francisco Green Room, second floor WHEN 10:30 am - noon Wednesday (July 10) Program begins at 11 am (See detailed schedule, below)
July 06, 2002
A rising number of San Franciscans are being infected with HIV that is already resistant to some classes of antiretroviral drugs, report researchers from the Gladstone Institute of Virology and Immunology in the July 10th issue of the Journal of the American Medical Association.
July 02, 2002
Although therapy with hormones was once thought to protect women’s hearts after menopause, a UCSF-led study has found that, at least for women with heart disease, estrogen plus progestin therapy does not reduce the risk of heart attack or death. The July 3, 2002 issue of the Journal of the American Medical Association (JAMA) contains two articles with the results of the Heart and Estrogen/Progestin Replacement Follow-up Study (HERS II).
July 01, 2002
A class of once-popular high blood pressure drugs, now used less frequently because of serious side effects, may be re-explored in light of San Francisco Veterans Affairs Medical Center research. The new study in mice suggests that drugs which block just one type of adrenalin receptor might be just as effective as the earlier, related drugs, but with fewer side effects.  The earlier drugs block more types of adrenalin receptors.
July 01, 2002
A class of once-popular high blood pressure drugs, now used less frequently because of serious side effects, may be re-explored in light of San Francisco Veterans Affairs Medical Center research. The new study in mice suggests that drugs which block just one type of adrenalin receptor might be just as effective as the earlier, related drugs, but with fewer side effects.  The earlier drugs block more types of adrenalin receptors.
June 27, 2002
Responding to the chronic shortage of pharmacists in the San Joaquin Valley, the University of California, San Francisco School of Pharmacy officially launches a new program July 2 to boost the number of pharmacists practicing in Valley communities.
June 26, 2002
A team led by UCSF medical researchers has discovered a new disorder that can cause severely elevated blood cholesterol levels and may affect several hundred thousand people in the U.S. and Europe to varying degrees. The malady is caused by a single gene defect.
June 26, 2002
The 2nd annual Lesbian Health Research Conference, to be held at UCSF in conjunction with San Francisco’s LGBT Pride Week Celebrations, will convene Bay Area community leaders to focus on understanding and eliminating barriers faced by lesbians, especially lesbians of color.
June 21, 2002
Children whose mothers have breast cancer can develop problems like nightmares and falling grades. In July, thanks to a grant from the Avon Foundation, some of them will participate in a new support group for Spanish-speaking children of patients at the San Francisco General Hospital Medical Center (SFGHMC) Breast Clinic.
June 20, 2002
A second type of Botulinum toxin - type B (brand name Myobloc®) —may be as effective as type A (brand name Botox®) for the treatment of facial wrinkles, according to UCSF researchers. The study, among the first to analyze the effectiveness of type B in prospective clinical trial, appears in the current issue of Otolaryngology - Head and Neck Surgery. 

Pages